Fig. 2From: Cost impact of a non-invasive, portable device for patient self-administration of chronic migraine in a UK National Health Service settingIncremental sensitivity analysis Botox versus TMS for individual funding request setting (increment from Botox to TMS in £; negative values indicate savings)Back to article page